Primary Liver Cancer Cohort of South China

Factors Influencing the Occurrence and Long-term Survival of Patients With Primary Liver Cancer: A Cohort Study in South China

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03297255

Enrollment

4000

Registered

2017-09-29

Start date

2013-01-01

Completion date

2025-12-31

Last updated

2017-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Liver Cancer

Keywords

Primary Liver Cancer; Cohort Study

Brief summary

This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer. Basic informations and detailed diagnosis informations (AJCC/TNM stage, MELD score, Child-Pugh score, and BCLC stage) were collected by professional doctors. Clinical outcomes (death, recurrence, and metastasis) will be followed up every two years after therapy.

Detailed description

Primary liver cancer (PLC) is highly malignant with high mortality which is particularly popular in China. Many factors are believed to associate with the occurrence and prognosis of liver cancer. This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* age 18-80 years * consistent with primary liver cancer diagnostic criteria * first diagnosis (from diagnosis to admission interval of less than a month) * did not do any treatment of liver cancer

Exclusion criteria

* refused to participate in this study * suffering from more than two kinds of primary tumors

Design outcomes

Primary

Measure	Time frame	Description
Time of Death	Up to 10 years	The exact death time of each participants will be checked in the government medical records system

Secondary

Measure	Time frame	Description
Time of recurrence	From date of diagnosis until the date of cancer recurrence or date of death from any cause, whichever came first, assessed up to 10 years	Time of recurrence will be obtained by telephone interview or medical treatment records
Time of metastasis	From date of diagnosis until the date of cancer metastasis or date of death from any cause, whichever came first, assessed up to 10 years	Time of metastasis will be obtained by telephone interview or medical treatment records

Countries

China

Contacts

Primary ContactZhu Huilian, Professor

zhuhl@mail.sysu.edu.cn+86 20 87331811

Backup ContactFang Aiping

fangaip@mail.sysu.edu.cn020-87335875

Outcome results